IBDEI1RV ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28308,1,3,0)
 ;;=3^Depress D/O d/t Anth Med Cond w/ Maj Dep-Like Ep
 ;;^UTILITY(U,$J,358.3,28308,1,4,0)
 ;;=4^F06.32
 ;;^UTILITY(U,$J,358.3,28308,2)
 ;;=^5003058
 ;;^UTILITY(U,$J,358.3,28309,0)
 ;;=F32.0^^115^1387^17
 ;;^UTILITY(U,$J,358.3,28309,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28309,1,3,0)
 ;;=3^MDD,Single Episode,Mild
 ;;^UTILITY(U,$J,358.3,28309,1,4,0)
 ;;=4^F32.0
 ;;^UTILITY(U,$J,358.3,28309,2)
 ;;=^5003521
 ;;^UTILITY(U,$J,358.3,28310,0)
 ;;=F32.1^^115^1387^18
 ;;^UTILITY(U,$J,358.3,28310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28310,1,3,0)
 ;;=3^MDD,Single Episode,Moderate
 ;;^UTILITY(U,$J,358.3,28310,1,4,0)
 ;;=4^F32.1
 ;;^UTILITY(U,$J,358.3,28310,2)
 ;;=^5003522
 ;;^UTILITY(U,$J,358.3,28311,0)
 ;;=F32.2^^115^1387^19
 ;;^UTILITY(U,$J,358.3,28311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28311,1,3,0)
 ;;=3^MDD,Single Episode,Severe
 ;;^UTILITY(U,$J,358.3,28311,1,4,0)
 ;;=4^F32.2
 ;;^UTILITY(U,$J,358.3,28311,2)
 ;;=^5003523
 ;;^UTILITY(U,$J,358.3,28312,0)
 ;;=F32.3^^115^1387^14
 ;;^UTILITY(U,$J,358.3,28312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28312,1,3,0)
 ;;=3^MDD,Single Episode w/ Psychotic Feat
 ;;^UTILITY(U,$J,358.3,28312,1,4,0)
 ;;=4^F32.3
 ;;^UTILITY(U,$J,358.3,28312,2)
 ;;=^5003524
 ;;^UTILITY(U,$J,358.3,28313,0)
 ;;=F32.4^^115^1387^16
 ;;^UTILITY(U,$J,358.3,28313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28313,1,3,0)
 ;;=3^MDD,Single Episode,In Partial Remission
 ;;^UTILITY(U,$J,358.3,28313,1,4,0)
 ;;=4^F32.4
 ;;^UTILITY(U,$J,358.3,28313,2)
 ;;=^5003525
 ;;^UTILITY(U,$J,358.3,28314,0)
 ;;=F32.5^^115^1387^15
 ;;^UTILITY(U,$J,358.3,28314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28314,1,3,0)
 ;;=3^MDD,Single Episode,In Full Remission
 ;;^UTILITY(U,$J,358.3,28314,1,4,0)
 ;;=4^F32.5
 ;;^UTILITY(U,$J,358.3,28314,2)
 ;;=^5003526
 ;;^UTILITY(U,$J,358.3,28315,0)
 ;;=F33.9^^115^1387^13
 ;;^UTILITY(U,$J,358.3,28315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28315,1,3,0)
 ;;=3^MDD,Recurrent Episode,Unspec
 ;;^UTILITY(U,$J,358.3,28315,1,4,0)
 ;;=4^F33.9
 ;;^UTILITY(U,$J,358.3,28315,2)
 ;;=^5003537
 ;;^UTILITY(U,$J,358.3,28316,0)
 ;;=F33.0^^115^1387^10
 ;;^UTILITY(U,$J,358.3,28316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28316,1,3,0)
 ;;=3^MDD,Recurrent Episode,Mild
 ;;^UTILITY(U,$J,358.3,28316,1,4,0)
 ;;=4^F33.0
 ;;^UTILITY(U,$J,358.3,28316,2)
 ;;=^5003529
 ;;^UTILITY(U,$J,358.3,28317,0)
 ;;=F33.1^^115^1387^11
 ;;^UTILITY(U,$J,358.3,28317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28317,1,3,0)
 ;;=3^MDD,Recurrent Episode,Moderate
 ;;^UTILITY(U,$J,358.3,28317,1,4,0)
 ;;=4^F33.1
 ;;^UTILITY(U,$J,358.3,28317,2)
 ;;=^5003530
 ;;^UTILITY(U,$J,358.3,28318,0)
 ;;=F33.2^^115^1387^12
 ;;^UTILITY(U,$J,358.3,28318,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28318,1,3,0)
 ;;=3^MDD,Recurrent Episode,Severe
 ;;^UTILITY(U,$J,358.3,28318,1,4,0)
 ;;=4^F33.2
 ;;^UTILITY(U,$J,358.3,28318,2)
 ;;=^5003531
 ;;^UTILITY(U,$J,358.3,28319,0)
 ;;=F33.3^^115^1387^7
 ;;^UTILITY(U,$J,358.3,28319,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28319,1,3,0)
 ;;=3^MDD,Recurrent Episode w/ Psychotic Feat
 ;;^UTILITY(U,$J,358.3,28319,1,4,0)
 ;;=4^F33.3
 ;;^UTILITY(U,$J,358.3,28319,2)
 ;;=^5003532
 ;;^UTILITY(U,$J,358.3,28320,0)
 ;;=F33.41^^115^1387^9
 ;;^UTILITY(U,$J,358.3,28320,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28320,1,3,0)
 ;;=3^MDD,Recurrent Episode,In Partial Remission
